GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (OTCPK:DVHGF) » Definitions » YoY EPS Growth

DVHGF (Devonian Health Group) YoY EPS Growth : 75.00% (As of Oct. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Devonian Health Group YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Devonian Health Group's YoY EPS Growth for the quarter that ended in Oct. 2024 was 75.00%.

Devonian Health Group's Earnings per Share (Diluted) for the three months ended in Oct. 2024 was $-0.00.


Devonian Health Group YoY EPS Growth Historical Data

The historical data trend for Devonian Health Group's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devonian Health Group YoY EPS Growth Chart

Devonian Health Group Annual Data
Trend Jun15 Jun16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -41.94 31.82 26.67 -18.18 76.92

Devonian Health Group Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.86 - 85.71 400.00 75.00

Devonian Health Group YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Devonian Health Group's YoY EPS Growth for the fiscal year that ended in Jul. 2024 is calculated as:

YoY EPS Growth (A: Jul. 2024 )
=(Earnings per Share (Diluted) (A: Jul. 2024 )-Earnings per Share (Diluted) (A: Jul. 2023 ))/ | Earnings per Share (Diluted) (A: Jul. 2023 ) |
=(-0.006--0.026)/ | -0.026 |
=76.92 %

Devonian Health Group's YoY EPS Growth for the quarter that ended in Oct. 2024 is calculated as:

YoY EPS Growth (Q: Oct. 2024 )
=(Earnings per Share (Diluted) (Q: Oct. 2024 )-Earnings per Share (Diluted) (Q: Oct. 2023 )) / | Earnings per Share (Diluted) (Q: Oct. 2023 )) |
=(-0.001--0.004)/ | -0.004 |
=75.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Devonian Health Group YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Devonian Health Group's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Devonian Health Group Business Description

Traded in Other Exchanges
Address
360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines